Dr. Kathy Rosema, DO

NPI: 1689628927
Total Payments
$5,932
2024 Payments
$1,389
Companies
47
Transactions
368
Medicare Patients
371
Medicare Billing
$3,959

Payment Breakdown by Category

Food & Beverage$5,932 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,932 368 100.0%

Top Paying Companies

Company Total Records Latest Year
Supernus Pharmaceuticals, Inc. $861.27 40 $0 (2024)
Sunovion Pharmaceuticals Inc. $582.62 44 $0 (2021)
ABBVIE INC. $574.32 37 $0 (2024)
PFIZER INC. $436.30 41 $0 (2023)
Novo Nordisk Inc $418.37 25 $0 (2024)
Otsuka America Pharmaceutical, Inc. $279.63 16 $0 (2024)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $210.22 12 $0 (2024)
ITI, Inc. $193.72 11 $0 (2023)
AstraZeneca Pharmaceuticals LP $181.51 14 $0 (2021)
Vanda Pharmaceuticals Inc. $163.45 7 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,389 61 Supernus Pharmaceuticals, Inc. ($367.49)
2023 $744.62 44 ITI, Inc. ($139.83)
2022 $427.78 27 Otsuka America Pharmaceutical, Inc. ($70.01)
2021 $632.05 36 AbbVie Inc. ($165.89)
2020 $394.76 27 Supernus Pharmaceuticals, Inc. ($153.04)
2019 $1,137 82 Sunovion Pharmaceuticals Inc. ($243.32)
2018 $964.56 72 Sunovion Pharmaceuticals Inc. ($270.43)
2017 $241.82 19 Otsuka America Pharmaceutical, Inc. ($32.38)

All Payment Transactions

368 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
12/23/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $16.19 General
Category: PSYCHIATRY
12/19/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $17.78 General
Category: Central Nervous System
12/13/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $17.49 General
Category: Cardio-renal
12/11/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $13.20 General
Category: Central Nervous System
12/09/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $25.38 General
Category: PSYCHIATRY
12/04/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $8.98 General
Category: PSYCHIATRY
12/03/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $24.81 General
Category: VILOXAZINE HYDROCHLORIDE
12/03/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $16.49 General
Category: RESPIRATORY
11/27/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $20.93 General
Category: PSYCHIATRY
11/26/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.31 General
Category: NEUROSCIENCE
11/24/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $24.03 General
Category: Neuropsychiatry
11/21/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $14.41 General
Category: PSYCHIATRY
11/19/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $17.12 General
Category: Central Nervous System
11/14/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $22.62 General
Category: Diabetes
11/14/2024 Lilly USA, LLC ZEPBOUND (Drug) Food and Beverage In-kind items and services $21.31 General
Category: Obesity
11/11/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $15.61 General
Category: Cardio-renal
11/08/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $22.30 General
Category: PSYCHIATRY
11/06/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.55 General
Category: NEUROSCIENCE
11/04/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $12.97 General
Category: PSYCHIATRY
10/31/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $23.64 General
Category: PSYCHIATRY
10/31/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $22.91 General
Category: RESPIRATORY
10/22/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.79 General
Category: NEUROSCIENCE
10/17/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $25.70 General
Category: Oncology
10/11/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $27.66 General
10/10/2024 Novo Nordisk Inc Saxenda (Drug), Wegovy Food and Beverage In-kind items and services $24.48 General
Category: Obesity

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 114 228 $3,831 $1,232
2022 2 76 92 $1,652 $563.70
2021 3 63 98 $2,692 $748.95
2020 5 118 160 $5,138 $1,414
Total Patients
371
Total Services
578
Medicare Billing
$3,959
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
83036 Hemoglobin a1c level Office 2023 47 82 $2,106 $780.64 37.1%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2023 52 129 $1,478 $414.09 28.0%
81003 Automated urinalysis test Office 2023 15 17 $246.84 $37.40 15.2%
83036 Hemoglobin a1c level Office 2022 36 42 $1,079 $402.17 37.3%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2022 40 50 $573.00 $161.53 28.2%
83036 Hemoglobin a1c level Office 2021 24 37 $950.16 $359.27 37.8%
82274 Stool analysis for blood, by fecal hemoglobin determination by immunoassay Office 2021 13 15 $1,215 $238.80 19.7%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2021 26 46 $527.16 $150.88 28.6%
G0180 Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem Office 2020 12 12 $1,955 $450.31 23.0%
83036 Hemoglobin a1c level Office 2020 31 41 $1,053 $395.07 37.5%
82274 Stool analysis for blood Office 2020 16 18 $1,013 $285.92 28.2%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2020 38 64 $733.44 $207.61 28.3%
36415 Insertion of needle into vein for collection of blood sample Office 2020 21 25 $383.25 $74.88 19.5%

About Dr. Kathy Rosema, DO

Dr. Kathy Rosema, DO is a Family Medicine healthcare provider based in Shelby, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689628927.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathy Rosema, DO has received a total of $5,932 in payments from pharmaceutical and medical device companies, with $1,389 received in 2024. These payments were reported across 368 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($5,932).

As a Medicare-enrolled provider, Rosema has provided services to 371 Medicare beneficiaries, totaling 578 services with total Medicare billing of $3,959. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Shelby, MI
  • Active Since 05/20/2006
  • Last Updated 05/19/2017
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1689628927

Products in Payments

  • LATUDA (Drug) $529.77
  • TROKENDI XR (Drug) $493.78
  • CAPLYTA (Drug) $403.94
  • VRAYLAR (Drug) $387.90
  • REXULTI (Drug) $374.21
  • Qelbree (Drug) $367.49
  • CHANTIX (Drug) $175.50
  • UBRELVY (Drug) $157.36
  • ELIQUIS (Drug) $129.29
  • Kerendia (Drug) $118.14
  • Ozempic (Drug) $113.93
  • FARXIGA (Drug) $105.97
  • BEXSERO (Biological) $94.12
  • Tresiba (Drug) $85.90
  • Austedo XR (Drug) $85.73
  • VYVANSE (Drug) $85.60
  • HETLIOZ (Drug) $84.50
  • Rybelsus (Drug) $76.76
  • QULIPTA (Drug) $76.51
  • JARDIANCE (Drug) $70.66

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Shelby